Comments
The delisting offer to the shareholders of Claris Lifesciences will open on Monday at the BSE. The company, which fixed the floor price at ₹351.60, plans to buy 2.72 crore shares from the public. The open offer closes on February 20. Shares of the company are not listed on the NSE. Non-promoters, including East Bridge Capital, Goldman Sachs, Cobra India and Morgan Stanley, currently hold 49.87 per cent stake in Claris Lifesciences.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.